Nephros (NEPH) Income from Non-Controlling Interests (2013 - 2022)
Nephros' (NEPH) quarterly Income from Non-Controlling Interests came in at $70000.0 in Q4 2022, up 14.75% year-on-year from $61000.0 in Q4 2021, and down 9.09% quarter-over-quarter from $77000.0 in Q3 2022.
Nephros (NEPH) Income from Non-Controlling Interests (2013 - 2022) Analysis & Trends
Nephros' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at $70000.0 for Q4 2022.
- On a quarterly basis, Income from Non-Controlling Interests rose 14.75% year-over-year to $70000.0 in Q4 2022; TTM through Dec 2022 was $276000.0, a 15.0% increase from a year earlier, with the FY2022 full-year figure at $276000.0, up 15.0% from the prior year.
- Income from Non-Controlling Interests slipped to $70000.0 in Q4 2022 per NEPH's latest filing, from $77000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $421000.0 in Q4 2019 and bottomed at -$93000.0 in Q4 2018.
- The 5-year median for Income from Non-Controlling Interests is $60000.0 (2020), against an average of $51111.1.
- Biggest YoY gain for Income from Non-Controlling Interests was 552.69% in 2019; the steepest drop was 475.0% in 2019.
- Year by year, Income from Non-Controlling Interests stood at -$93000.0 in 2018, then surged by 552.69% to $421000.0 in 2019, then plunged by 85.51% to $61000.0 in 2020, then changed by 0.0% to $61000.0 in 2021, then gained by 14.75% to $70000.0 in 2022.
- Per Business Quant, the three latest NEPH Income from Non-Controlling Interests figures stand at $70000.0 (Q4 2022), $77000.0 (Q3 2022), and $66000.0 (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -18.70 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Jun 30, 2020 | 60,000.00 |
| Mar 31, 2020 | 59,000.00 |
| Dec 31, 2019 | 421,000.00 |
| Sep 30, 2019 | -60,000.00 |
| Jun 30, 2019 | -61,000.00 |
| Mar 31, 2019 | -59,000.00 |
| Dec 31, 2018 | -93,000.00 |
| Sep 30, 2018 | 16,000.00 |
| Sep 30, 2014 | -3.43 Mn |
| Jun 30, 2013 | 607,000.00 |